Type 2 diabetes mellitus coincident with pulmonary tuberculosis is associated with heightened systemic type 1, type 17, and other proinflammatory cytokines.
about
Influence of diabetes mellitus on the immunity to human tuberculosis.Defining a research agenda to address the converging epidemics of tuberculosis and diabetes. Part 2: Underlying biological mechanisms.Chromatin decondensation and T cell hyperresponsiveness in diabetes-associated hyperglycemia.Diminished plasma levels of common γ-chain cytokines in pulmonary tuberculosis and reversal following treatmentSystems Immunology of Diabetes-Tuberculosis Comorbidity Reveals Signatures of Disease Complications.Diabetes and immunity to tuberculosis.Diminished systemic and antigen-specific type 1, type 17, and other proinflammatory cytokines in diabetic and prediabetic individuals with latent Mycobacterium tuberculosis infectionCoincident pre-diabetes is associated with dysregulated cytokine responses in pulmonary tuberculosisThe effect of hyperglycaemia on in vitro cytokine production and macrophage infection with Mycobacterium tuberculosis.NK-CD11c+ Cell Crosstalk in Diabetes Enhances IL-6-Mediated Inflammation during Mycobacterium tuberculosis Infection.Clinical Pharmacokinetics of Rifampin in Patients with Tuberculosis and Type 2 Diabetes Mellitus: Association with Biochemical and Immunological Parameters.Type 2 diabetes - Tuberculosis co-morbidity is associated with diminished circulating levels of IL-20 subfamily of cytokines.Impaired Cytokine but Enhanced Cytotoxic Marker Expression in Mycobacterium tuberculosis-Induced CD8+ T Cells in Individuals With Type 2 Diabetes and Latent Mycobacterium tuberculosis Infection.High Prevalence and Heterogeneity of Diabetes in Patients With TB in South India: A Report from the Effects of Diabetes on Tuberculosis Severity (EDOTS) StudyDyslipidemia rather than Type 2 Diabetes Mellitus or Chronic Periodontitis Affects the Systemic Expression of Pro- and Anti-Inflammatory Genes.Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections.Acquired immunodeficiencies and tuberculosis: focus on HIV/AIDS and diabetes mellitus.Tuberculosis-diabetes co-morbidity is characterized by heightened systemic levels of circulating angiogenic factors.Effect of standard tuberculosis treatment on naive, memory and regulatory T-cell homeostasis in tuberculosis-diabetes co-morbidity.Clinical and epidemiological aspects of cases of tuberculosis associated with diabetes in Salvador, Bahia, Brazil.Profiling leucocyte subsets in tuberculosis-diabetes co-morbidity.Mycobacterial infection induces higher interleukin-1β and dysregulated lung inflammation in mice with defective leukocyte NADPH oxidase.Type 2 diabetes mellitus is associated with altered CD8(+) T and natural killer cell function in pulmonary tuberculosis.Plasma interleukin-22 levels are associated with prediabetes and type 2 diabetes in the Han Chinese population.Prevalence of dysglycemia and clinical presentation of pulmonary tuberculosis in Western India.Patients with type 1 diabetes mellitus have impaired IL-1β production in response to Mycobacterium tuberculosis.IL-22: An Underestimated Player in Natural Resistance to Tuberculosis?
P2860
Q30234363-A3133E13-064B-43FC-B681-9A554221875CQ30234697-BA5EC05F-20FF-4A86-A539-1C25AC20015CQ30601364-7270106D-3651-48DB-8FCF-9119312A168AQ33610319-E8424EC4-B570-4287-B729-2D5C04684984Q33700655-2D7BC529-CD0D-42F3-AFC5-7DDAF2759AD9Q34424824-182ECA2F-32DB-4F27-B70A-0CC5885FB79DQ34430226-CFD2253C-8CB8-4C61-B676-DF9FEF4864E5Q34505943-DB70EC1A-7CDE-4BB5-9D97-6D587C2CDC1AQ35558240-96A36143-763D-4D4C-A404-6E0BBB122F29Q36175034-D2820447-EEAE-410A-B77B-49ECB3EE0CCEQ36290609-F3A68BF8-2F9F-452F-9FE9-B56E9E59F463Q36338729-751883BA-99A3-4C6C-903F-40ECF1CC8D60Q36562830-D54F1507-A431-4EE5-ADD2-6653DC203F80Q37094652-BACA8AE0-136B-4B0E-8E0B-BBDF26D5AE58Q37681581-9A9F74A4-47BB-4FEF-A5DC-D86987EE89D1Q38254986-89BDD6B7-3008-45F7-A846-9F9DD17E66EFQ38363794-89F032BC-2C6D-4996-A0E1-0AC91360855EQ39310832-AC6FB739-6AAC-4CCF-B0C7-95CFFE69A2E3Q39691092-448D48A7-C1B5-4215-AD9A-CE311FD54FF9Q40126066-BE3EE411-356C-45B6-AC8C-718B57C7DA5EQ40815734-02F73798-020B-4173-B2A8-15A148BC21DDQ46243855-339EC709-5F37-4375-B161-E808C1396F58Q46316702-E117AB8C-87DE-4FB2-B8B5-8B1100BDD7F9Q49246280-588BD2AC-BE45-4A2E-9F87-F948CCA73F71Q49348211-0FCAE83F-F2B3-41A1-9E4D-ACF388774FA9Q49364796-B5B62BF4-53E0-4036-974F-82463D7C57ABQ57492004-222FFEF1-12BD-4B33-9CCB-1E208F75A4AD
P2860
Type 2 diabetes mellitus coincident with pulmonary tuberculosis is associated with heightened systemic type 1, type 17, and other proinflammatory cytokines.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Type 2 diabetes mellitus coinc ...... her proinflammatory cytokines.
@en
Type 2 diabetes mellitus coinc ...... her proinflammatory cytokines.
@nl
type
label
Type 2 diabetes mellitus coinc ...... her proinflammatory cytokines.
@en
Type 2 diabetes mellitus coinc ...... her proinflammatory cytokines.
@nl
prefLabel
Type 2 diabetes mellitus coinc ...... her proinflammatory cytokines.
@en
Type 2 diabetes mellitus coinc ...... her proinflammatory cytokines.
@nl
P2093
P2860
P921
P1476
Type 2 diabetes mellitus coinc ...... her proinflammatory cytokines.
@en
P2093
Mohideen S Jawahar
Nathella Pavan Kumar
Rathinam Sridhar
Subash Babu
Vaithilingam V Banurekha
P2860
P304
P356
10.1513/ANNALSATS.201305-112OC
P577
2013-10-01T00:00:00Z